Flex Conference (Physical / Digital)

International Conference on Neuro Oncology (ICNO - 27)

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals.

SDG 3 SDG 3 — Good Health and Well-being
SDG 4 SDG 4 — Quality Education
SDG 9 SDG 9 — Industry, Innovation and Infrastructure
Track 01

Advancements in Neuro Oncology

This track focuses on the latest research and innovations in neuro oncology, highlighting novel therapeutic approaches and treatment modalities. Participants will explore cutting-edge studies that aim to improve patient outcomes in neuro cancer.

Track 02

Neurosurgery Techniques and Innovations

This session will delve into the latest surgical techniques and technologies in neurosurgery for treating brain and spinal cord tumors. Discussions will include minimally invasive approaches and their impact on patient recovery and quality of life.

Track 03

Neuroimaging in Cancer Diagnosis

This track emphasizes the role of advanced neuroimaging techniques in the diagnosis and monitoring of central nervous system malignancies. Experts will present findings on how imaging can enhance treatment planning and patient management.

Track 04

Psychosocial Aspects of Neuro Oncology

This session addresses the psychosocial challenges faced by patients with neuro cancer and their families. It aims to foster discussions on supportive care strategies and the importance of mental health in oncology.

Track 05

Clinical Trials in Neuro Oncology

This track will present ongoing and completed clinical trials focused on neuro oncology, discussing their methodologies, outcomes, and implications for future research. Participants will gain insights into the challenges and successes of trial design in this field.

Track 06

Neuroinflammation and Cancer

This session explores the relationship between neuroinflammation and cancer progression, examining how inflammatory processes can influence tumor behavior. Researchers will discuss potential therapeutic targets within these pathways.

Track 07

Genetic and Molecular Insights in Neuro Oncology

This track highlights the genetic and molecular underpinnings of neuro cancers, focusing on the role of biomarkers in diagnosis and treatment. Presentations will cover recent discoveries in cancer genomics and their clinical applications.

Track 08

Cognitive Disorders in Cancer Patients

This session investigates the impact of neuro oncology treatments on cognitive function and the prevalence of cognitive disorders among cancer patients. Experts will discuss assessment tools and interventions to support cognitive health.

Track 09

Ethics in Neuro Oncology Research

This track addresses the ethical considerations in neuro oncology research, including informed consent, patient autonomy, and the implications of emerging therapies. Discussions will aim to establish best practices for ethical conduct in clinical trials.

Track 10

Vascular Neurology and Cancer

This session focuses on the intersection of vascular neurology and oncology, exploring how vascular conditions can complicate cancer treatment. Participants will discuss strategies for managing these comorbidities in neuro oncology patients.

Track 11

Future Directions in Neuro Oncology

This track aims to envision the future of neuro oncology, discussing emerging trends, technologies, and research directions. Experts will share their perspectives on the evolving landscape of treatment and care for neuro cancer.

Important Dates

Early Bird Registration :12th January 2027

Paper Submission Deadline :17th January 2027

Last Date of Registration : 27th January 2027

Date of Conference : 11th - 12th February 2027